Your browser is no longer supported. Please, upgrade your browser.
Settings
HAE Haemonetics Corporation daily Stock Chart
HAE [NYSE]
Haemonetics Corporation
Index- P/E69.60 EPS (ttm)1.48 Insider Own0.80% Shs Outstand50.34M Perf Week-5.95%
Market Cap5.22B Forward P/E25.31 EPS next Y4.06 Insider Trans-4.22% Shs Float49.93M Perf Month-6.60%
Income76.50M PEG5.80 EPS next Q0.42 Inst Own- Short Float2.53% Perf Quarter-6.06%
Sales988.50M P/S5.28 EPS this Y42.10% Inst Trans1.42% Short Ratio2.32 Perf Half Y-13.29%
Book/sh11.66 P/B8.82 EPS next Y33.05% ROA6.20% Target Price141.57 Perf Year1.75%
Cash/sh2.70 P/C38.04 EPS next 5Y12.00% ROE13.10% 52W Range63.41 - 140.36 Perf YTD-10.53%
Dividend- P/FCF47.74 EPS past 5Y35.40% ROI9.60% 52W High-26.76% Beta0.71
Dividend %- Quick Ratio1.20 Sales past 5Y1.70% Gross Margin49.00% 52W Low62.12% ATR4.46
Employees3004 Current Ratio2.20 Sales Q/Q-4.30% Oper. Margin10.50% RSI (14)45.22 Volatility4.69% 4.04%
OptionableYes Debt/Eq0.65 EPS Q/Q-13.90% Profit Margin7.70% Rel Volume1.27 Prev Close107.92
ShortableYes LT Debt/Eq0.52 EarningsMay 05 BMO Payout0.00% Avg Volume545.12K Price102.80
Recom1.70 SMA20-2.15% SMA50-1.78% SMA200-10.69% Volume690,318 Change-4.74%
May-06-20Downgrade Barrington Research Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Jan-10-20Initiated Needham Buy $138
Aug-07-19Reiterated Barrington Research Outperform $116 → $139
May-14-19Upgrade Raymond James Mkt Perform → Outperform $110
May-08-19Reiterated Barrington Research Outperform $112 → $116
Aug-09-18Reiterated Barrington Research Outperform $90 → $118
Feb-07-18Reiterated Barrington Research Outperform $57 → $71
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-08-17Reiterated Barrington Research Outperform $48 → $57
Aug-08-17Upgrade Barrington Research Mkt Perform → Outperform $48
Jul-13-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Feb-07-17Downgrade Barrington Research Outperform → Mkt Perform
Nov-08-16Upgrade Barrington Research Mkt Perform → Outperform $41
Nov-07-16Reiterated The Benchmark Company Hold $32 → $34
Sep-20-16Downgrade CJS Securities Market Outperform → Market Perform
Aug-15-16Downgrade Sidoti Buy → Neutral
Aug-02-16Reiterated The Benchmark Company Hold $28 → $32
Aug-02-16Reiterated Jefferies Buy $32 → $40
May-16-16Upgrade Goldman Sell → Neutral
Jun-03-20 06:45AM  
01:10AM  
May-28-20 04:18PM  
May-26-20 12:39AM  
May-11-20 08:03AM  
May-06-20 11:33AM  
May-05-20 09:01PM  
May-04-20 04:41PM  
01:36PM  
11:02AM  
09:08AM  
Apr-28-20 12:33PM  
Apr-24-20 09:05AM  
Apr-17-20 01:13PM  
Apr-16-20 12:10PM  
Apr-06-20 09:09AM  
Apr-03-20 08:00AM  
Apr-02-20 06:45AM  
Mar-30-20 04:15PM  
12:00PM  
Mar-26-20 04:52PM  
Mar-18-20 06:47AM  
Mar-09-20 09:20AM  
Mar-05-20 11:30AM  
Mar-03-20 09:22AM  
Mar-02-20 10:42AM  
Feb-18-20 08:52AM  
Feb-11-20 07:59AM  
Feb-07-20 11:30AM  
Feb-06-20 09:58PM  
Feb-05-20 10:51AM  
Feb-04-20 07:30AM  
06:00AM  
Feb-03-20 10:58AM  
Jan-28-20 12:31PM  
Jan-27-20 04:46PM  
Jan-23-20 10:48AM  
09:01AM  
Jan-22-20 10:44AM  
10:07AM  
10:05AM  
Jan-21-20 09:21AM  
09:04AM  
08:17AM  
Jan-20-20 09:49AM  
09:39AM  
07:34AM  
Jan-17-20 08:42AM  
07:10AM  
Jan-16-20 10:01AM  
09:43AM  
07:01AM  
Jan-15-20 10:18AM  
06:48AM  
Jan-14-20 10:01AM  
09:27AM  
06:30AM  
Jan-13-20 10:03AM  
09:42AM  
09:40AM  
07:30AM  
Jan-10-20 08:38AM  
Jan-09-20 10:19AM  
07:20AM  
05:52AM  
Jan-08-20 09:23AM  
09:00AM  
Jan-07-20 10:11AM  
10:08AM  
09:35AM  
09:09AM  
07:56AM  
Jan-06-20 04:24PM  
08:53AM  
08:52AM  
07:53AM  
Jan-03-20 10:59AM  
10:56AM  
10:48AM  
08:36AM  
Jan-02-20 10:01AM  
09:40AM  
09:19AM  
09:14AM  
09:14AM  
Dec-31-19 11:12AM  
10:53AM  
10:45AM  
Dec-30-19 11:47AM  
10:17AM  
09:31AM  
Dec-27-19 12:05PM  
10:26AM  
10:16AM  
Dec-26-19 11:42AM  
10:06AM  
Dec-24-19 11:21AM  
11:17AM  
09:28AM  
09:26AM  
Haemonetics Corporation, a healthcare company, provides hematology products and solutions. It operates through Japan, EMEA, North America Plasma, and All Other segments. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables, such as plasma collection containers and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; OrthoPAT, a perioperative autotranfusion system for orthopedic procedures; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldstein DanVP, Corporate ControllerMay 18Sale101.7210110,2741,709May 19 06:10 PM
Goldstein DanVP, Corporate ControllerMay 15Sale100.44424,2181,810May 19 06:10 PM
Llorens JosepSVP, Global ManufacturingMay 15Sale100.4410710,7472,663May 19 05:51 PM
Scanlan JacquelineSVP, Global Human ResourcesMay 15Sale100.4411011,0484,466May 19 05:34 PM
Basil Michelle LEVP and General CounselMay 15Sale100.4420320,38914,161May 19 05:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerMay 15Sale100.4422122,19710,190May 19 05:10 PM
Simon, ChristopherPresident & CEOMay 15Sale100.441,008101,244303,757May 19 07:06 PM
KROLL MARK WDirectorApr 09Option Exercise45.456,573298,74329,320Apr 13 05:12 PM
KROLL MARK WDirectorApr 09Sale102.0010,9021,112,00418,418Apr 13 05:12 PM
Goldstein DanVP, Corporate ControllerApr 08Sale97.1239938,7511,852Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 07Sale103.9120120,8862,251Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 06Option Exercise34.422,60789,7335,059Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 06Sale101.622,607264,9232,452Apr 08 05:10 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 10Sale99.6320720,6234,383Mar 10 05:46 PM
Basil Michelle LEVP and General CounselMar 09Sale98.0039538,71014,364Mar 10 06:16 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 09Sale98.0011811,5644,590Mar 10 05:46 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 06Option Exercise38.431,29949,9216,007Mar 10 05:46 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 06Sale100.501,299130,5504,708Mar 10 05:46 PM
MEELIA RICHARD JDirectorNov 11Option Exercise45.456,573298,74336,640Nov 13 05:17 PM
GELBMAN RONALD GDirectorNov 11Option Exercise39.3716,926666,29565,310Nov 13 05:21 PM
Bolorforosh SaidEVP, Chief Technology OfficerNov 11Sale118.2733940,0941,977Nov 13 05:24 PM
GELBMAN RONALD GDirectorNov 11Sale118.2616,9262,001,66948,384Nov 13 05:21 PM
MEELIA RICHARD JDirectorNov 11Sale118.156,573776,60030,067Nov 13 05:17 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 29Sale122.691,448177,65510,411Oct 29 08:20 PM
Goldstein DanVP, Corporate ControllerOct 29Sale122.6923729,0782,452Oct 29 08:32 PM
Goldstein DanVP, Corporate ControllerOct 28Sale120.3310012,0332,689Oct 29 08:32 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 28Sale120.331,155138,98111,859Oct 29 08:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 25Option Exercise34.2111,231384,21324,245Oct 29 08:20 PM
Goldstein DanVP, Corporate ControllerOct 25Option Exercise34.211,45649,8104,245Oct 29 08:32 PM
Goldstein DanVP, Corporate ControllerOct 25Sale120.321,456175,1862,789Oct 29 08:32 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 25Sale120.1711,2311,349,63413,014Oct 29 08:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 09Sale123.9922,7042,815,07913,014Oct 10 04:52 PM
Basil Michelle LEVP and General CounselOct 09Sale123.9610,6331,318,11713,138Oct 10 04:56 PM
Scanlan JacquelineSVP, Global Human ResourcesOct 09Sale123.942,909360,5394,695Oct 10 05:03 PM
Scanlan JacquelineSVP, Global Human ResourcesOct 08Sale122.342,295280,7707,604Oct 10 05:03 PM
Basil Michelle LEVP and General CounselOct 08Sale122.348,8831,086,74623,771Oct 10 04:56 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 08Sale122.3418,9502,318,34335,718Oct 10 04:52 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 01Option Exercise41.645,718238,09820,178Oct 03 05:22 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 01Sale125.807,164901,19813,014Oct 03 05:22 PM
Scanlan JacquelineSVP, Global Human ResourcesSep 09Option Exercise93.521,308122,3246,226Sep 11 04:34 PM
Scanlan JacquelineSVP, Global Human ResourcesSep 09Sale127.441,531195,1114,695Sep 11 04:34 PM
Llorens JosepSVP, Global ManufacturingSep 05Sale129.9410113,1242,770Sep 09 04:53 PM
Bolorforosh SaidEVP, Chief Technology OfficerAug 30Option Exercise93.5283277,8092,973Sep 03 04:46 PM
Bolorforosh SaidEVP, Chief Technology OfficerAug 30Sale133.7365787,8612,316Sep 03 04:46 PM
Simon, ChristopherPresident & CEOAug 19Sale137.4350,8696,990,927304,572Aug 21 05:31 PM
Goldstein DanVP, Corporate ControllerAug 09Option Exercise93.5247544,4223,264Aug 12 04:20 PM
Goldstein DanVP, Corporate ControllerAug 09Sale133.2347563,2842,789Aug 12 04:20 PM
GELBMAN RONALD GDirectorAug 08Sale134.151,696227,51848,384Aug 12 04:25 PM
Simon, ChristopherPresident & CEOJul 01Sale121.795,008609,924241,143Jul 02 05:47 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 17Option Exercise41.642,890120,3408,564Jun 18 04:30 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 17Sale112.493,646410,1394,918Jun 18 04:30 PM
Goldstein DanVP, Corporate ControllerJun 13Sale110.589410,3952,789Jun 17 04:30 PM
Goldstein DanVP, Corporate ControllerJun 12Sale109.37394,2652,883Jun 13 04:35 PM
Bolorforosh SaidEVP, Chief Technology OfficerJun 12Sale109.37697,5472,141Jun 13 04:33 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 12Sale109.3710811,8125,674Jun 13 04:31 PM
Basil Michelle LEVP and General CounselJun 12Sale109.3723125,26413,138Jun 13 04:29 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 12Sale109.3719020,78014,460Jun 13 04:27 PM
Simon, ChristopherPresident & CEOJun 12Sale109.371,248136,494246,151Jun 13 04:25 PM
Goldstein DanVP, Corporate ControllerJun 10Sale104.3819220,0412,922Jun 12 04:19 PM
Basil Michelle LEVP and General CounselJun 07Option Exercise38.434,872187,23120,556Jun 10 04:22 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 07Sale103.3820821,5035,782Jun 10 04:25 PM
Basil Michelle LEVP and General CounselJun 07Sale103.497,187743,80113,369Jun 10 04:22 PM
Goldstein DanVP, Corporate ControllerJun 07Sale103.38788,0643,114Jun 10 04:27 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 07Sale103.3841142,48914,650Jun 10 04:14 PM
Simon, ChristopherPresident & CEOJun 07Sale103.382,834292,979247,399Jun 10 04:11 PM
Basil Michelle LEVP and General CounselJun 06Option Exercise41.646,148256,00321,832Jun 10 04:22 PM
Goldstein DanVP, Corporate ControllerJun 06Option Exercise41.641,10746,0954,299Jun 10 04:27 PM
Goldstein DanVP, Corporate ControllerJun 06Sale103.251,107114,2983,192Jun 10 04:27 PM
Basil Michelle LEVP and General CounselJun 06Sale103.256,148634,78115,684Jun 10 04:22 PM